A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab.
A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab. Mult Scler. 2019 05; 25(6):811-818.